1999
DOI: 10.1016/s0022-5347(05)68627-2
|View full text |Cite
|
Sign up to set email alerts
|

Alterations in the Nitric Oxide Synthase Binding Sites and Non-Adrenergic, Non-Cholinergic Mediated Smooth Muscle Relaxation in the Diabetic Rabbit Bladder Outlet: Possible Relevance to the Pathogenesis of Diabetic Cystopathy

Abstract: Alterations of both the NOS binding sites and functional responses to NANC nerve stimulation suggest that NO may have a pathophysiological role in the urinary bladder dysfunction associated with DM.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
20
1

Year Published

1999
1999
2017
2017

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 39 publications
(22 citation statements)
references
References 41 publications
1
20
1
Order By: Relevance
“…In a previous study, NO production was reported to be increased in the urethra of DM rabbits through the measurement of nicotinamide adenine dinucleotide phosphate diaphorase, a marker of NOS activity (24). However, in the present study, the concentration of NO was determined directly in DM rats, and the results indicated that the NO concentration was significantly decreased in DM rats.…”
Section: Discussioncontrasting
confidence: 71%
“…In a previous study, NO production was reported to be increased in the urethra of DM rabbits through the measurement of nicotinamide adenine dinucleotide phosphate diaphorase, a marker of NOS activity (24). However, in the present study, the concentration of NO was determined directly in DM rats, and the results indicated that the NO concentration was significantly decreased in DM rats.…”
Section: Discussioncontrasting
confidence: 71%
“…TH and VAChT protein are well established and commonly employed presynaptic markers of sympathetic and parasympathetic fibers respectively [28,29]. NOS1 is also recognized as an important controller of genitourinary function via its involvement in non-adrenergic non-cholinergic pathways [15,19,27,31]. In our initial studies of control tissues we found these markers to be localized to certain mouse bladder regions, in that TH was most prevalent in the lamina propria region, while VAChT was most prevalent in the smooth muscle region, and NOS1 was widely distributed.…”
Section: Discussionmentioning
confidence: 99%
“…Diabetes-related urinary bladder dysfunction in humans has commonly been attributed to altered neuronal control and/or neuronal injury [3,4], and such changes have also been observed in several animal models (e.g., rat, guinea pig, hamster, rabbit) [7,[17][18][19]. However, a review of the literature shows no consensus since studies have reported an increase, decrease or no effect to various muscarinic and adrenergic agonists [7,10,12], and there is a lack of such investigations in any mouse model during diabetes.…”
Section: Introductionmentioning
confidence: 99%
“…This is in good accordance with ®ndings in other uro-genital smooth muscle organs (corpus cavernosum and urethra), where it was shown that diabetes impairs nerve-mediated relaxation. 5,34 In the vascular bed, several investigators have shown that diabetes causes impaired endothelium-dependent relaxation. 35 ± 38 Possible mechanisms behind the diabetes-related impairment of the NO system may be decreased releaseaformation of NO due to decreased NOS activity, 39 de®cit in the substrate availability, 35 alterations of the NOS binding sites, 34 reduction in nerve density, 33 or decreased sensitivity to NO.…”
Section: Discussionmentioning
confidence: 99%
“…5,34 In the vascular bed, several investigators have shown that diabetes causes impaired endothelium-dependent relaxation. 35 ± 38 Possible mechanisms behind the diabetes-related impairment of the NO system may be decreased releaseaformation of NO due to decreased NOS activity, 39 de®cit in the substrate availability, 35 alterations of the NOS binding sites, 34 reduction in nerve density, 33 or decreased sensitivity to NO. 36 In order to identify a possible step of the cGMP pathway responsible for the diabetes related impairment of the NO system in our experiments, investigations were carried out to measure NOS activity in tissue from diabetic and non-diabetic animals.…”
Section: Discussionmentioning
confidence: 99%